Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity

Abstract

In carefully selected patients who have not responded to less invasive treatments, continuous intrathecal baclofen infusion is likely to lead to worthwhile functional benefits. Continuous intrathecal baclofen infusion has an acceptable cost/benefit ratio compared with other interventions that are funded by the health service.